Literature DB >> 16398499

pH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study.

Vijay A Sethuraman1, Kun Na, You Han Bae.   

Abstract

The feasibility of pH-sensitive polymeric nanoparticles that effectively target the acidic extracellular matrix of tumors is demonstrated. Plasmid DNA was complexed with polyethyleneimine (PEI) and further with a pH-sensitive diblock copolymer, poly(methacryloyl sulfadimethoxine) (PSD)-block-PEG (PSD-b-PEG), to obtain naonparticles. The shielding/deshielding of nanoparticles was tested along with cell viability and transfection efficiency at physiological and tumor pH. The nanoparticles composed of DNA/PEI/PSD-b-PEG were 300 nm in size and showed low cytotoxicity and transfection at pH 7.4 due to shielding of PEI by PSD-b-PEG. The PSD-b-PEG bound to PEI/DNA complex decreased the interaction of PEI positive charges with cells and reduced the cytotoxicity by 60%. At pH 6.6, the nanoparticles demonstrated high cytotoxicity and transfection, indicating PSD-b-PEG detachment from the nanoparticles and permit PEI to interact with cells. PSD-b-PEG is able to discern the small difference in pH between normal and tumor tissues and hence has remarkable potential in drug targeting to tumor areas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16398499     DOI: 10.1021/bm0503571

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  30 in total

Review 1.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

2.  pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.

Authors:  Hyejung Mok; Omid Veiseh; Chen Fang; Forrest M Kievit; Freddy Y Wang; James O Park; Miqin Zhang
Journal:  Mol Pharm       Date:  2010-09-14       Impact factor: 4.939

Review 3.  Polymeric nucleic acid carriers: current issues and novel design approaches.

Authors:  Han Chang Kang; Kang Moo Huh; You Han Bae
Journal:  J Control Release       Date:  2012-07-04       Impact factor: 9.776

Review 4.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.

Authors:  Lei Miao; C Michael Lin; Leaf Huang
Journal:  J Control Release       Date:  2015-08-12       Impact factor: 9.776

5.  Smart Polymeric Gels: Redefining the Limits of Biomedical Devices.

Authors:  Somali Chaterji; Il Keun Kwon; Kinam Park
Journal:  Prog Polym Sci       Date:  2007-08       Impact factor: 29.190

Review 6.  Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery.

Authors:  Christopher L Grigsby; Kam W Leong
Journal:  J R Soc Interface       Date:  2009-09-04       Impact factor: 4.118

7.  Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery.

Authors:  Rupa R Sawant; Shravan Kumar Sriraman; Gemma Navarro; Swati Biswas; Riddhi A Dalvi; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-02-25       Impact factor: 12.479

8.  A biodegradable pH-sensitive micelle system for targeting acidic solid tumors.

Authors:  Vijay A Sethuraman; Myung Cheon Lee; You Han Bae
Journal:  Pharm Res       Date:  2007-11-13       Impact factor: 4.200

Review 9.  Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.

Authors:  James W Yockman; Andrew Kastenmeier; Harold M Erickson; Jonathan G Brumbach; Matthew G Whitten; Aida Albanil; Dean Y Li; Sung Wan Kim; David A Bull
Journal:  J Control Release       Date:  2008-07-06       Impact factor: 9.776

10.  Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.

Authors:  Diane-Charlotte Imbs; Marie-Noelle Paludetto; Sylvie Négrier; Helen Powell; Thierry Lafont; Melanie White-Koning; Etienne Chatelut; Fabienne Thomas
Journal:  Invest New Drugs       Date:  2015-11-16       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.